Cargando…

An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease, and about 30%–40% of patients will develop relapsed/refractory DLBCL. In this study, we aimed to develop a gene signature to predict survival outcomes of DLBCL patients based on the autophagy-related genes (ARGs). M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xuan, He, Ying-Zhi, Liu, Dan, Lin, Chao-Ran, Liang, Dan, Huang, Rui, Wang, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280409/ https://www.ncbi.nlm.nih.gov/pubmed/35846146 http://dx.doi.org/10.3389/fgene.2022.862179

Ejemplares similares

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma
por: Xu, Hong, et al.
Publicado: (2022)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021)

Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma
por: Pan, Mengmeng, et al.
Publicado: (2021)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas
por: Ren, Peng, et al.
Publicado: (2022)

Integrative analysis of a necroptosis-related gene signature of clinical value and heterogeneity in diffuse large B cell lymphoma
por: Pan, Yu-Biao, et al.
Publicado: (2022)

Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma
por: Liu, Dan, et al.
Publicado: (2023)

Systematic Analysis of Competing Endogenous RNA Networks in Diffuse Large B-Cell Lymphoma and Hodgkin’s Lymphoma
por: Kang, Juanjuan, et al.
Publicado: (2020)

A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer
por: Li, Xiaoping, et al.
Publicado: (2021)

Autophagy-Related Long Non-coding RNA Signature as Indicators for the Prognosis of Uveal Melanoma
por: Cui, Yi, et al.
Publicado: (2021)

Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer
por: Lin, Xu-tao, et al.
Publicado: (2021)

Combined multiomics analysis reveals the mechanism of CENPF overexpression-mediated immune dysfunction in diffuse large B-cell lymphoma in vitro
por: Yang, Dan, et al.
Publicado: (2022)

Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts
por: Liang, Shengjie, et al.
Publicado: (2022)

Constructing a signature based on the SIRT family to help the prognosis and treatment sensitivity in glioma patients
por: Xuan, Feiyue, et al.
Publicado: (2022)

Prognosis-Predictive Signature and Nomogram Based on Autophagy-Related Long Non-coding RNAs for Hepatocellular Carcinoma
por: Jia, Yu, et al.
Publicado: (2020)

Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer
por: Dai, Yin-wei, et al.
Publicado: (2022)

Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
por: Yao, Zhi-Yong, et al.
Publicado: (2021)

High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy
por: Salwa, Amreen, et al.
Publicado: (2023)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer
por: Song, Guoda, et al.
Publicado: (2022)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis
por: Xiang, Chenxi, et al.
Publicado: (2021)

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy
por: Li, Zhe, et al.
Publicado: (2022)

Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma
por: Liu, Chen, et al.
Publicado: (2022)

A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
por: Chai, Rui-Chao, et al.
Publicado: (2019)

A Novel Pyroptosis-Related Gene Signature for Predicting Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer
por: Xing, Xuewei, et al.
Publicado: (2023)

The rs78378222 prevalence and the copy loss of the protective allele A in the tumor tissue of diffuse large B-cell lymphoma
por: Voropaeva, Elena N., et al.
Publicado: (2020)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)

An efficient five-lncRNA signature for lung adenocarcinoma prognosis, with AL606489.1 showing sexual dimorphism
por: Liang, Jiali, et al.
Publicado: (2022)

Diffuse large B-cell lymphoma with continuously elevated immunoglobulin M following treatment: a case report with pathologic, immunophenotypic, and molecular analyses
por: Xiao, Fei, et al.
Publicado: (2023)

Development and verification of the glycolysis-associated and immune-related prognosis signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2022)

Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
por: Ding, Jianfeng, et al.
Publicado: (2022)

A Cholesterol Homeostasis-Related Gene Signature Predicts Prognosis of Endometrial Cancer and Correlates With Immune Infiltration
por: Chen, Yili, et al.
Publicado: (2021)

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
por: Hou, Yue, et al.
Publicado: (2023)

Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer
por: Yu, Jing, et al.
Publicado: (2021)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1gmqpfk64veh1ghcjb5nc80371